uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
14.28
-0.11 (-0.76%)
At close: Apr 24, 2025, 4:00 PM
14.16
-0.12 (-0.84%)
After-hours: Apr 24, 2025, 4:22 PM EDT
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
$129,756
Profits / Employee
-$1,146,201
Market Cap
772.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
QURE News
- 3 days ago - uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130 - Seeking Alpha
- 5 days ago - uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting - Seeking Alpha
- 7 days ago - Why Is Gene Therapy Developer uniQure Stock Trading Higher On Thursday? - Benzinga
- 7 days ago - uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington's Disease - GlobeNewsWire
- 2 months ago - uniQure Announces 2024 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 2 months ago - uniQure N.V.: A Potential Huntington's Play - Seeking Alpha
- 2 months ago - uniQure: Gene Therapy Specialist Looks Set For Upside As Huntington's Approval Beckons - Seeking Alpha
- 2 months ago - uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years - Benzinga